Check out our most popular compounded medications! Get Started
Pseudoephedrine HCl 120 mg/Chlorpheniramine Maleate 8 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the active ingredients over an extended period, providing sustained therapeutic effects. This formulation is used to treat symptoms of Allergic Rhinitis, Sinusitis, Nasal Congestion, Common Cold, and Hay Fever. The slow release mechanism also reduces dosing frequency, improving patient compliance for medications requiring a controlled and prolonged release profile.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Pseudoephedrine HCl 120 mg/Chlorpheniramine Maleate 8 mg Slow Release Capsules are a compounded formulation designed to treat a variety of conditions, including allergies, colds, and sinus congestion. This medication is formulated with Methocel E4M, a type of controlled-release polymer, which ensures the gradual release of the active ingredients over an extended period of time. This slow-release mechanism offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance, particularly for medications requiring a controlled and prolonged release profile.
The combination of Pseudoephedrine HCl and Chlorpheniramine Maleate in this formulation works synergistically to alleviate symptoms associated with allergies, colds, and sinus congestion. These symptoms may include sneezing, runny nose, itchy eyes, nasal congestion, and sinus pressure.
It is crucial to use this medication as directed by your healthcare provider. Overuse or misuse can lead to unwanted side effects or reduced effectiveness. This formulation is not recommended for use in children under the age of 12 due to the potential for serious side effects. Always consult with your healthcare provider if you have any questions or concerns about this medication.
If you have any questions about Pseudoephedrine HCl 120 mg/Chlorpheniramine Maleate 8 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. Our team of experienced and dedicated pharmacists is always ready to assist you with your medication needs and to help you understand how to get the most benefit from your medication.
This formulation of Pseudoephedrine HCl 120 mg/Chlorpheniramine Maleate 8 mg Slow Release Capsules is specifically designed for the treatment of symptoms associated with allergies, hay fever, and the common cold. It is crucial to understand that this formulation is not intended to treat any other conditions or diseases.
The capsules are formulated with Methocel E4M, a type of controlled-release polymer. This design allows for the gradual release of the encapsulated medication or active ingredient over an extended period of time. This results in sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
Patients should be aware that this formulation may interact with other medications they are taking. These include, but are not limited to, monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, other antihistamines, and anticholinergics. Additionally, this formulation may interact with certain foods, such as alcohol, which should be avoided while taking this medication.
It is important to note that this formulation may cause side effects such as drowsiness, dry mouth, blurred vision, and difficulty urinating. As such, it should not be taken while driving or operating heavy machinery.
Prescribers should also be aware of the potential interactions of this formulation with other medications they are prescribing. These include, but are not limited to, monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, other antihistamines, and anticholinergics. They should also be aware that this formulation may interact with certain foods, such as alcohol, which should be avoided while taking this medication.
Prescribers should also be aware of the potential side effects of this formulation, such as drowsiness, dry mouth, blurred vision, and difficulty urinating. As such, it should not be prescribed to patients who will be driving or operating heavy machinery.
If you have any questions about this formulation or its interactions, please do not hesitate to reach out for further information.
Pseudoephedrine HCl 120 mg/Chlorpheniramine Maleate 8 mg Slow Release Capsules is a compounded formulation designed to alleviate symptoms associated with allergies, hay fever, and the common cold. This combination medication works by blocking the action of histamine, a substance in the body that triggers allergic symptoms, and by constricting the blood vessels in the nasal passages to alleviate congestion.
The unique feature of this formulation is its slow-release mechanism, which is achieved through the use of Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the active ingredients over an extended period, providing sustained therapeutic effects, reducing the need for frequent dosing, and enhancing patient compliance, particularly for medications that require a controlled and prolonged release profile.
Pseudoephedrine HCl, a decongestant, works by narrowing the blood vessels in the nose to reduce congestion. Chlorpheniramine Maleate, an antihistamine, works by blocking the action of histamine, a substance in the body that triggers allergic symptoms. Together, these active ingredients provide relief from symptoms such as sneezing, runny nose, itchy eyes, and nasal congestion.
This formulation may also be used to treat other conditions as determined by your healthcare provider. The recommended dosage is one capsule taken orally every 12 hours, or as directed by your healthcare provider. It is important not to exceed two capsules within a 24-hour period. The capsule should be swallowed whole with a full glass of water and should not be crushed, chewed, or broken.
If you have any questions or require further information about this formulation, please do not hesitate to contact us.
This formulation of Pseudoephedrine HCl 120 mg/Chlorpheniramine Maleate 8 mg Slow Release Capsules is designed with Methocel E4M, a controlled-release polymer. This technology allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects, reduced dosing frequency, and improved patient compliance. This formulation is not only used for its primary purpose but also to treat a variety of other conditions. These include allergic conjunctivitis, urticaria, and pruritus. It can also serve as an adjunct to other treatments for conditions such as asthma, bronchitis, and chronic obstructive pulmonary disease.
It is also beneficial for alleviating symptoms of hay fever like itchy eyes, sneezing, and nasal congestion. Additionally, it can be used to treat symptoms of sinusitis such as nasal congestion, facial pain, and headache. If you have any questions about the use of this formulation for any other condition, please do not hesitate to reach out for more information.
Methocel E4M is a type of controlled-release polymer. It is designed to release the encapsulated medication or active ingredient gradually over an extended period of time. This offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
Slow-release capsules offer several benefits. They provide sustained therapeutic effects, meaning the medication continues to work over a longer period of time. They also reduce the frequency of dosing, which can improve patient compliance, especially for those who struggle to remember to take their medication regularly.
The active ingredients in these capsules are Pseudoephedrine HCl 120 mg and Chlorpheniramine Maleate 8 mg.
Pseudoephedrine HCl is a decongestant that shrinks blood vessels in the nasal passages. This helps to reduce congestion and improve breathing.
Chlorpheniramine Maleate is an antihistamine that reduces the effects of the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.
As these capsules are slow-release, they are designed to be taken less frequently than regular medication. However, the exact dosing schedule should be determined by your healthcare provider based on your specific needs and condition.
If you miss a dose, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take two doses at the same time or extra doses.
No, these capsules should not be broken, crushed, or chewed. They are designed to release the medication slowly over time. Breaking or crushing the capsule could result in too much of the drug being released at once.
Common side effects may include dizziness, dry mouth/nose/throat, constipation, or upset stomach. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
Before using this medication, tell your doctor or pharmacist if you are pregnant or breastfeeding. They will be able to advise you on whether it is safe for you to take.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
